The Medtech Accelerator has been set up to facilitate the early stage development of innovations in the broad area of medical technology (devices, diagnostics, software and eHealth) that meet unmet clinical needs within the NHS.
Led by HEE as a joint venture with New Anglia and Greater Cambridge & Greater Peterborough (GCGP) Local Enterprise Partnerships (LEPs), and the Eastern AHSN, the Medtech Accelerator supports and finances projects at an early stage in order to maximise the potential for success in bringing new life enhancing technologies to patients. A total of £1.5 million is available with individual awards to be made of between £15,000 and £125,000 to innovation projects that show the potential to create future spin-out companies primarily out of NHS organisations. Awards are aimed at supporting proof of concept work which might include IP protection, market analysis, prototype development and testing, clinical evaluation, regulatory support and pilot product production.
Medtech Accelerator Submission and Award Process
Delivering innovative technology to patients..
The Medtech Accelerator has a clear and simple application process to provide its proof of concept awards.
Apply for an Award
The Medtech Accelerator welcomes applications Primarily from individuals or teams within eligible NHS organisations. It has an open call and applications can be submitted at any time. The Medtech Accelerator Awards Committee meet on a quarterly basis to review applications and decide on awards to be made.
Regional anaesthesia is directed at a specific region of the body to allow a surgical operation or provide post-operative pain relief. SAFIRA is a quicker, cheaper and safer method to inject regional anaesthetics.
Prominent ears affect an estimated 5-10% of the UK population. EarFold™ is a pioneering implant technology as an alternative to conventional otoplasty surgery in the correction of prominent ears.
Solid tumours can be treated with energy based ablation techniques as a minimally invasive alternative to conventional surgery. BETA is a novel tissue ablation technology that addresses significant performance limitations of current Radio Frequency Ablation.
Tracheostomy is one of the most frequently performed surgical procedures on the critically ill patient to establish an alternative airway passage. HandyTrak™ is a novel stoma creating device for use in percutaneous tracheostomies.